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The spontaneous expression of neural markers, already demonstrated in bone marrow (BM) mesenchymal stem cells (MSCs), has
been considered as evidence of the MSCs’ predisposition to differentiate toward neural lineages, supporting their use in stem cell-
based therapy for neural repair. In this study we have evaluated, by immunocytochemistry, immunoblotting, and flow cytometry
experiments, the expression of neural markers in undifferentiatedMSCs from different sources: human adipose stem cells (hASCs),
human skin-derived mesenchymal stem cells (hS-MSCs), human periodontal ligament stem cells (hPDLSCs,) and human dental
pulp stem cells (hDPSCs). Our results demonstrate that the neuronal markers 𝛽III-tubulin and NeuN, unlike other evaluated
markers, are spontaneously expressed by a very high percentage of undifferentiated hASCs, hS-MSCs, hPDLSCs, and hDPSCs.
Conversely, the neural progenitor marker nestin is expressed only by a high percentage of undifferentiated hPDLSCs and hDPSCs.
Our results suggest that the expression of 𝛽III-tubulin and NeuN could be a common feature of stem cells and not exclusive to
neuronal cells. This could result in a reassessment of the use of 𝛽III-tubulin and NeuN as the only evidence proving neuronal
differentiation. Further studies will be necessary to elucidate the relevance of the spontaneous expression of these markers in stem
cells.
1. Introduction
Mesenchymal stem cells (MSCs) from bone marrow (BM-
MSCs) are the adult stem cells that have been best char-
acterized but other similar populations have been isolated
and described from several tissues such as adipose tissue,
umbilical cord blood, skin, skeletal muscle, and teeth. When
MSCs are isolated from various tissues, a heterogeneous pool
of cells may be obtained, so it is crucial to distinguish MSCs
from other cells that may exhibit a similar phenotype in
culture [1]. In order to allow for an unequivocal isolation
and identification of MSCs, a single marker or set of markers
is required. In 2006 the International Society of Cellular
Therapy established three minimal criteria for identifying
MSCs and among these were the expression of the specific
antigens CD73, CD90, and CD105 and the lack of the
expression of CD34, CD45, and HLA-DR [2]. Subsequently,
novel and alternative markers have been proposed which
may be common or specific for MSCs derived from various
sources [1]. Furthermore, marker expression is an important
tool in order to prove MSC differentiation into different
lineages.
We and other researchers have shown that undiffer-
entiated BM-MSCs express neuronal and glial differentia-
tion markers [3, 4]. This finding has been considered as
evidence of the BM-MSCs’ predisposition to differentiate
toward neural lineages, thereby supporting the use of these
cells in therapy for neurodegenerative diseases and other
neurological disorders. Many clinical trials have been under-
taken with BM-MSCs in neural repair [5] and, although
promising evidence has been obtained, further studies are
necessary. Some problems arise from the use of BM-MSCs
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because these cells are not very abundant, and their number
and proliferative capacity decrease with the donor’s age.
Adipose stem cells (ASCs), dental stem cells (DSCs), and
skin-derived mesenchymal stem cells (S-MSCs) represent
a very interesting source of stem cells due to their great
accessibility and availability and more rapid proliferative
kinetics and greater expansion capabilities than BM-MSCs
[6–8]. In order to verify whether there may be a possible
use for these MSC-like cells in stem cell-based therapies for
neurodegenerative diseases and nervous system injuries, it
is essential to establish whether these stem cells, like BM-
MSCs, spontaneously express neural markers. To this end, we
evaluated by immunocytochemistry, immunoblotting, and
fluorescence-activated cell sorting (FACS) experiments the
expression of neuronal, glial, and neural progenitor markers
at various culture passages in undifferentiated human ASCs
(hASCs), human S-MSCs (hS-MSCs), human periodontal
ligament stem cells (hPDLSCs), and human dental pulp stem
cells (hDPSCs).
2. Materials and Methods
2.1. hASC Isolation and Characterization. hASC isolation and
characterization were performed as previously described [9].
Briefly, subcutaneous adipose tissues were obtained from
healthy patients undergoing plastic surgery after written
consent and Institutional Review Board (IBR) authorization
from the IRCCS Galeazzi Orthopaedic Institute of Milan.
Raw lipoaspirates (15–150mL) were enzymatically digested
with 0.075% type I collagenase at 37∘C under continuous
agitation for 30 minutes.The stromal vascular fraction (SVF)
was centrifuged (1200 g × 10 minutes) and filtered through
a sterile medication lint and cells were plated (105 cells/cm2)
in DMEM (Sigma-Aldrich, Milan, Italy) supplemented with
50U/mL penicillin, 50 𝜇g/mL streptomycin, and 2mM L-
glutamine (Sigma-Aldrich) (complete DMEM) plus 10% FBS.
hASCs have been analysed for MSC-related cell surface anti-
gens expression and for their differentiation ability toward
cells of the mesodermal lineage [10]. For the experiments
performed in this study, hASCs were maintained in complete
DMEM plus 10% defined FBS in a 5% CO
2
humidified
incubator at 37∘C.
2.2. hS-MSC Isolation and Characterization. hS-MSC iso-
lation and characterization were performed as previously
described [11, 12]. Skin biopsies of the mammary gland were
obtained from healthy adult patients undergoing cosmetic
plastic surgery after informed consent. In brief, the samples,
with a size range between 10 and 15mm, were postoper-
atively collected and rinsed twice with PBS supplemented
with antibiotic-antimycotic solution (100 units/mLpenicillin,
100 𝜇g/mL streptomycin, and 0.25 𝜇g/mL amphotericin B
(Lonza, Verviers, Belgium). Under a stereo microscope, the
fat tissue and most of the derma were carefully removed with
forceps, and the remaining dermal-epidermal samples were
finely shredded into smaller strips and then transferred into
six-well plates with the culture medium Mesenchymal Stem
Cell Growth Medium bullet kit (MSCGM) (Lonza, Verviers,
Belgium). The cultures were maintained in MSCGM in a 5%
CO
2
humidified incubator at 37∘C. After 14 days of culture,
numerous cells forming colonies (CFU-F) migrated from the
explants; nonadherent cells and residual dermal tissue were
removed and the medium was replaced with a fresh one.
Subsequently, the medium was changed twice a week. When
the adherent cells reached confluence, they were detached
by 0.125% trypsin and 1mM ethylenediaminetetraacetic acid
(EDTA) for 3 minutes. The released cells were collected and
replated for subculturing in culture flasks with the same
culture medium.
hS-MSCs expressed MSC-related cell surface antigens
[12] and were able to differentiate toward mesodermal lin-
eages [13]. For the experiments performed in this study, hS-
MSCs were cultured in MSCGM in a 5% CO
2
humidified
incubator at 37∘C.
2.3. hPDLSC and hDPSC Isolation and Characterization.
Healthy human third molars extracted during orthodontic
treatment were collected from patients, after obtaining writ-
ten informed consent, at the Department of Dentistry, San
Gerardo Hospital, Monza. All interventions were performed
under anesthesia due to total mucosal or bone impaction of
dental elements. After local anesthesia, performed in a plessic
way in association with mepivacaine 2% with a 1 : 100000
adrenalin ratio, a full thickness flapwas completed.Moreover,
through osteotomy, impacted third molars were enucleated
and then preserved for amaximumof 1 hour in a sterile saline
solution (PBS). The following procedures were done under
sterile conditions.
To obtain hPDLSCs, periodontal ligament tissue was
gently scraped from the surface of the middle third of
the root. The tissue was placed in a 75 cm2 culture flask
with complete DMEM and incubated at 37∘C in 5% CO
2
.
To obtain hDPSCs, the teeth were sectioned longitudinally
in a mesiodistal direction with a piezoelectric ultrasonic
device (OT7 insert) under abundant irrigation with sterile
salt solution (0.9% NaCl) to expose the pulp chamber. The
pulp tissue was separated by means of an MOD.31W hand
excavator; it was then placed in a 75 cm2 culture flask with
complete DMEM plus 10% FBS and incubated at 37∘C in 5%
CO
2
.
hPDLSCs and hDPSCs expressed MSC-related cell sur-
face antigens and were able to differentiate toward mesoder-
mal lineages (paper in preparation).
For the experiments performed in this study, hPDLSCs
and hDPSCs were cultured in complete DMEM plus 10%
defined FBS in a 5% CO
2
humidified incubator at 37∘C.
2.4. Immunofluorescence Experiments. The expression of dif-
ferentiation markers was determined in hASCs (P3, P6, and
P16), hS-MSCs (P4, P8, and P16), hPDLSCs (P2, P4, and
P8), and hDPSCs (P2, P4, and P8) by immunofluorescence
experiments after 14 days from plating on glass slides in
35mmdiameter dishes (104 cells/dish) in the culturemedium
used for cell expansion without adding any differentiative
agent.
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Cells were fixed with 4% paraformaldehyde for 10min
and then treated with 0.1M glycine (Sigma-Aldrich, St.
Louis, MO) for 10min. Cells were incubated for 30min
at room temperature with a blocking solution (5% BSA,
0.6% Triton X-100 in PBS) and for 30min at 37∘C with
1mg/mL RNAse (Sigma-Aldrich, St. Louis, MO). Incuba-
tion with the following primary antibodies was performed
overnight at 4∘C: mouse anti-human nestin (Chemicon,
Temecula, CA; 1 : 50); rabbit anti-human nestin (Chemicon,
Temecula, CA; 1 : 200); anti-𝛽III-tubulin (Covance, Berkeley,
CA; 1 : 100); anti-NeuN (Chemicon, Temecula, CA; 1 : 50);
anti-Neurofilament (DakoCytomation, Glostrup, Denmark;
1 : 100); anti-GFAP (Sigma-Aldrich, St. Louis, MO; 1:100);
anti-S100 (Chemicon, Temecula, CA; 1 : 100); mouse anti-
osteopontin (Santa Cruz Biotechnology, Inc; 1 : 100); anti-
osteocalcin (Abcam, Cambridge, UK; 1 : 100); anti-PPAR𝛾2
(Abcam, Cambridge, UK; 1:500).The following day, cells were
washed with PBS plus 0.3% Triton X-100 and incubated for 1
hour in the dark with appropriate fluorochrome-conjugated
secondary antibodies (Alexa Fluor 488, 555, 647 anti-mouse
and anti-rabbit) (Invitrogen, Oregon, USA; 1 : 200). Propid-
ium iodide (Sigma-Aldrich, St. Louis, MO; 2.5 𝜇g/mL) as a
nuclear marker, or Alexa Fluor 546-conjugated phalloidin
(Invitrogen, Oregon, USA; 1 : 200) as a cytoskeleton fila-
mentous actin marker, was used. After incubation with the
appropriate fluorochrome-conjugated secondary antibodies,
cells werewashedwith PBS andmountedwith polyvinyl alco-
hol. Microscopy analysis was performed with laser confocal
microscopy (Radiance 2100; Biorad Laboratories, Hercules,
CA,USA) and noise reductionwas achieved by usingKalman
filters during acquisition.
2.5. Cell Lysate and Immunoblotting Analysis. Total cellular
extracts from hASCs, hS-MSCs, hPDLSCs, and hDPSCs were
prepared as previously described [14]. To obtain nuclear
protein extracts the Ronca et al. protocol was performed
[15]. Protein concentration was determined by the Bradford
assay using a Coomassie Protein Assay Reagent Kit (Pierce,
Rockford, IL, USA). After electrophoresis onto 13% SDS-
PAGE, the proteins were transferred to nitrocellulose filters
and immunoblotting analysis was performed using anti-𝛽III-
tubulin (1 : 3000) and anti-NeuN (1 : 200) antibodies. Anti-
actin (1 : 1000, Santa Cruz, Temecula, CA, USA) antibody was
used as a loading control. After incubationwith primary anti-
bodies, the membrane was washed and then incubated with
the appropriate horseradish peroxidise conjugated secondary
antibodies (1 : 2000) (anti-mouse, Chemicon, Temecula, CA;
anti-rabbit, PerkinElmer, Boston, MA; anti-goat, Santa Cruz
Temecula, CA, USA) and the ECL chemiluminescence sys-
tem (Amersham, Arlington Heights, IL, USA) was used.
2.6. Flow Cytometry Analysis. hASCs, hS-MSCs, hPDLSCs,
and hDPSCs were trypsinized and centrifuged at 500 g for
5min. Then, after washes with PBS, cells were fixed in
2% paraformaldehyde, permeabilized with 0.5% saponin for
15min (for 𝛽III-tubulin staining), or fixed and permeabilized
with cold methanol/acetone (3 : 1) for 30min (for NeuN).
Then cells were incubated with anti-𝛽III-tubulin (1 : 100)
or anti-NeuN (1 : 50) for 30min at 4∘C. After incubation with
primary antibodies, cells were washed and then incubated
with appropriate APC- or FITC-conjugated secondary anti-
bodies for additional 30min at room temperature. As control,
cells were incubated only with the secondary antibody. At
least 40,000 events were acquired with a cytometer (BD
FACScantoI, BD Biosciences, San Jose, CA, USA) in a user-
defined gate. Data were analyzed using FACS Diva software.
2.7. Statistical Analysis. Differences in the number (%) of
cells expressing a specific differentiation marker in different
passages were analyzed by using one-way analysis of variance
(ANOVA). For each marker, an average value of positive cells
after 14 days of culture was calculated. Data were expressed
as means ± SD. Comparisons of mean values for the passages
were analyzed using Tukey’s multiple comparison test. A five
percent probability (𝑃 < 0.05) was used as the level of
significance.
3. Results
3.1. Expression of Mesengenic and Neural Markers by Undif-
ferentiated hASCs, hS-MSCs, hPDLSCs, and hDPSCs. At
different culture passages and for each analysed passage
at day 14 from plating we evaluated, in undifferentiated
hASCs, hS-MSCs, hPDLSCs, and hDPSCs, and cultured, in
the presence of serumand in the absence of any differentiative
agent, the expression of the following differentiationmarkers:
the neuronal markers of 𝛽III-tubulin [16], NeuN [17], and
Neurofilament (NF) [18]; the glial markers of GFAP [19] and
S100 [20]; the osteogenic markers of osteopontin (OPN) [21]
and osteocalcin (OCN) [22]; the adipogenic marker PPAR𝛾2
[23]. Moreover, we analyzed the expression of the neuro-
progenitor marker nestin [24]. For this purpose, we carried
out immunofluorescence experiments and for each marker
we obtained the percentage of positive cells by averaging
experimental results. In each experiment, in ten randomly
chosen microscopic fields, positive cells were counted and
averaged. In all the experiments the markers retained their
proper cellular localization.
3.1.1. Undifferentiated hASCs. For each marker, the percent-
age of hASC positive cells was obtained by averaging the
experimental results using cells from 3 healthy donors. The
data reported in Table 1 refer to an average value (mean ± SD)
for a positivemarker after 14 days of culture at P3, P6, and P16.
A small number of undifferentiated hASCs expressed the
neuroprogenitor marker nestin (Figure 1(b)). The expression
of nestin was limited to about 1–5% of cells at P3 and P6, and
at P16 no nestin positive cells were observed (Table 1).
As shown in Figure 1, undifferentiated hASCs expressed
early and late neuronal markers. At all passages examined,
more than 90% of undifferentiated hASCs resulted positive
for 𝛽III-tubulin (an early neuronal marker) that showed a
major concentration in perinuclear areas (Figure 1(e)), while
NeuN (a late neuronal marker) was localized in the nucleus
(Figure 1(h)) and expressed by about 60–80% of cells. The
expression of the late neuronal marker NF was not observed
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Table 1: Undifferentiated hASC expression of differentiation markers at different passages after 14 days of culture. The number of positive
cells for each marker is expressed as % ± SD (—: no positive cells).
Marker Passage Significant differences (𝑃 value < 0.05, ANOVA)
P3 P6 P16
Nestin 5 ± 2.5 1.5 ± 0.5 — All ns
𝛽III-tubulin 90 ± 5 90.67 ± 3.06 91.67 ± 3.06 All ns
NeuN 75 ± 5 65 ± 5 65 ± 5 All ns
GFAP — 10 ± 3.54 75 ± 7.07 P6 versus P16
Table 2: Undifferentiated hS-MSC expression of differentiation markers at different passages after 14 days of culture. The number of positive
cells for each marker is expressed as % ± SD (—: no positive cells). When the values are very heterogeneous we report the % of positive cells
for each donor.
Marker Passage Significant differences (𝑃 value < 0.05, ANOVA)
P4 P8 P16
Nestin 12.33 ± 2.52 @ 3.17 ± 1.76 All ns
𝛽III-tubulin 85 ± 5 90.67 ± 1.53 91.67 ± 0.58 All ns
NeuN 78.33 ± 7.64 75 ± 5 ∞ All ns
GFAP — # ∗ All ns
@Donor 1: 2%; donor 2: 22%; donor 3: 7%.
∞Donor 1: 80%; donor 2: 5%; donor 3: 78%.
#Donor 1 and donor 2: negative; donor 3: 30%.
∗Donor 1: negative; donor 2 and donor 3: 70%.
at any culture passage examined. The expression of the glial
marker GFAP was not observed at P3, while at P6 about
10% of cells were positive and at P16 this number increased
to about 75%. Often GFAP expression was not equally dis-
tributed in the cytoplasm, and zones with different labelling
intensities were observed. On the contrary, the expression
of the glial marker S100 was not observed at any culture
passage examined. Regarding the expression of mesengenic
markers, undifferentiated hASCs did not express PPAR𝛾2
(adipogenic marker), OPN (early osteogenic marker), or
OCN (late osteogenic marker) at any passage examined.
Moreover, double immunolabeling studies revealed that
undifferentiated hASCs that were positive for NeuN also
expressed 𝛽III-tubulin, while some 𝛽III-tubulin positive cells
were NeuN negative (Figures 2(a)–2(c)). The percentage of
nestin positive cells was very limited but these cells were
always 𝛽III-tubulin positive (Figures 2(d)–2(f)) and, in some
cases, they were, respectively, NeuN positive (Figures 2(g)–
2(i)) and GFAP positive (Figures 2(j)–2(l)).
3.1.2. Undifferentiated hS-MSCs. For each marker, the per-
centage of hS-MSC positive cells was obtained by averaging
the experimental results using cells from 3 healthy donors.
The data reported in Table 2 refer to an average value (mean
± SD) for a positive marker after 14 days of culture at P4, P8,
and P16.
The expression of the neuroprogenitor marker nestin was
extended to about 10–15% of cells at P4 (Figure 3(b)). At P8,
variability between donors was observed. At P16, on the other
hand, for all donors examined, the number of cells expressing
nestin decreased to about 1–3% (Table 2).
Undifferentiated hS-MSCs expressed the early neuronal
marker 𝛽III-tubulin and at all passages examined more than
90% of cells resulted positive for this protein (Figure 3(e)).
The late neuronal marker NeuN was expressed by about 80%
of hS-MSCs (Figure 3(h)), at P4 and P8. At p16, on the other
hand, variability between donors was observed NeuN being
expressed by 80% of cells in two donors and by 5% of cells
in one donor. The expression of the late neuronal marker NF
was not observed at any culture passage examined.
The glial marker GFAP was not expressed at P4, while
at P8 its expression was observed only in hS-MSCs deriving
from one of the donors examined where about 30% of cells
were GFAP positive. At P16, hS-MSCs obtained from two of
the donors examined were GFAP positive (about 70%), while
cells from the third donor were GFAP negative. Often GFAP
expression was not equally distributed in the cytoplasm, and
zones with different labelling intensities were observed.
Undifferentiated hS-MSCs did not express S100 (glial
marker), PPAR𝛾2 (adipogenic marker), OPN (early osteo-
genic marker), or OCN (late osteogenic marker) at any
passage examined.
Moreover, double immunolabeling studies revealed that
undifferentiated hS-MSCs that were positive for NeuN also
expressed 𝛽III-tubulin, while some 𝛽III-tubulin positive cells
were NeuN negative (Figures 4(a)–4(c)). The percentage of
nestin positive cells was very limited but these cells were
always 𝛽III-tubulin positive (Figures 4(d)–4(f)) and, in some
cases, they were, respectively, NeuN positive (Figures 4(g)–
4(i)) and GFAP positive (Figures 4(j)–4(l)).
3.1.3. Undifferentiated hPDLSCs. For each marker, the per-
centage of hPDLSC positive cells was obtained by averaging
experimental results using cells from 3 healthy donors. The
data reported in Table 3 refer to an average value (mean± SD)
for a positive marker after 14 days of culture at P2, P4, and P8.
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Table 3: Undifferentiated hPDLSC expression of differentiation markers at different passages after 14 days of culture.The number of positive
cells for each marker is expressed as % ± SD.
Marker Passage Significant differences (𝑃 value < 0.05, ANOVA)
P2 P4 P8
Nestin 30 ± 5 31.67 ± 14.43 33.33 ± 11.55 All ns
𝛽III-tubulin 90 ± 5 90.67 ± 3.06 91.33 ± 1.53 All ns
NeuN 50 ± 34.64 40 ± 26.46 41.67 ± 28.43 All ns
(a) (b) (c)
(d) (e) (f)
(g) (h) (i)
Figure 1: Spontaneous expression of neural markers by undifferentiated hASCs (P3), after 14 days of culture. Actin filaments were stained
in red by phalloidin ((a), (d), and (g)), and neural markers were labelled in green. Few cells were nestin positive (b). Most of cells were
𝛽III-tubulin positive (e). Numerous cells were NeuN positive with nuclear localization (h). Merges ((c), (f), and (i)). Bars: 50 𝜇m.
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(a) (b) (c)
(d) (e) (f)
(g) (h) (i)
(j) (k) (l)
Figure 2: Spontaneous coexpression of neural markers by undifferentiated hASCs (P6) after 14 days of culture. NeuN-positive cells ((a): red)
were always 𝛽III-tubulin positive ((b): green) as shown in merge (c). Most of cells were 𝛽III-tubulin positive ((d): red), and the few nestin-
positive cells ((e), (h), and (k): green) were always 𝛽III-tubulin positive as shown in merge (f), while only in some case they were positive,
respectively, for NeuN ((g): red) and GFAP ((j): red) as shown in merges (i) and (l). Bars: 50𝜇m.
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Table 4: Undifferentiated hDPSC expression of differentiation markers at different passages after 14 days of culture. The number of positive
cells for each marker is expressed as % ± SD.
Marker Passage Significant differences (𝑃 value < 0.05, ANOVA)
P2 P4 P8
Nestin 33.33 ± 11.55 35 ± 8.66 25 ± 8.66 All ns
𝛽III-tubulin 92.67 ± 2.52 91.67 ± 1.53 90 ± 3.61 All ns
NeuN 61.67 ± 12.58 53.33 ± 5.77 58.33 ± 10.41 All ns
(a) (b) (c)
(d) (e) (f)
(g) (h) (i)
Figure 3: Spontaneous expression of neural markers by undifferentiated hS-MSCs (P4) after 14 days of culture. Actin filaments were stained
in red by phalloidin ((a), (d), and (g)), and neural markers were labelled in green. Some cells were nestin positive (b). Most of the cells were
𝛽III-tubulin positive (e) and numerous cells were NeuN positive with nuclear localization (h). Merges ((c), (f), and (i)). Bars: 50 𝜇m.
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(a) (b) (c)
(d) (e) (f)
(g) (h) (i)
(j) (k) (l)
Figure 4: Spontaneous coexpression of neural markers by undifferentiated hS-MSCs (P8) after 14 days of culture. Most of cells were 𝛽III-
tubulin positive ((a), (d): red) and the numerous NeuN-positive cells ((b): green) were always 𝛽III-tubulin positive as shown in merge (c).
The few nestin-positive cells ((e), (h), and (k): green) were always 𝛽III-tubulin positive as shown in merge (f), while only in some cases they
were positive, respectively, for NeuN ((g): red) and GFAP ((j): red) as shown in merges (i) and (l). Bars: 50𝜇m.
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Table 5: Overall means of the percentage of cells expressing 𝛽III-tubulin and NeuN in hASCs, hS-MSCs, hPDLSCs, and hDPSCs after 14
days of culture. The number of positive cells for each marker is expressed as % ± SD.
Marker MSC type Significant differences (𝑃 value < 0.05, ANOVA)
hASCs hS-MSCs hPDLSCs hDPSCs
𝛽III-tubulin 90.78 ± 3.4 89.11 ± 4.1 91.11 ± 3.3 91.44 ± 2.6 All ns
NeuN 68.33 ± 6.6 69.22 ± 24.6 43.89 ± 26.43 57.78 ± 9.39 All ns
(a) (b) (c)
(d) (e) (f)
(g) (h) (i)
Figure 5: Spontaneous expression of neural markers by undifferentiated hPDLSCs (P4), after 14 days of culture. Actin filaments were stained
in red ((a), (d), and (g)), and neural markers were labelled in green. About one-third of the cells in culture were nestin positive (b). Most of
cells were 𝛽III-tubulin positive (e). Numerous cells were NeuN positive with nuclear localization (h). Merges ((c), (f), and (i)). Bars: 50 𝜇m.
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(a) (b) (c)
(d) (e) (f)
(g) (h) (i)
Figure 6: Spontaneous coexpression of neural markers by undifferentiated hPDLSCs (P8) after 14 days of culture. Most of cells were 𝛽III-
tubulin positive ((a), (d): red) and the numerous NeuN-positive cells ((b): green) were always 𝛽III-tubulin positive as shown in merge (c).
The nestin-positive cells ((e), (h): green) were always 𝛽III-tubulin positive as shown in merge (f), while only in some cases they were positive
for NeuN ((g): red) as shown in merge (i). Bars: 50𝜇m.
At all the examined passages about 30% of undifferenti-
ated hPDLSCs expressed the neuroprogenitor marker nestin
(Figure 5(b)), while more than 90% of cells resulted positive
for 𝛽III-tubulin (Figure 5(e)). NeuN expression showed vari-
ability between donors. At all the examined passages NeuN
was expressed by 10% of cells in one donor and by 60–70% of
cells derived from the other two donors (Figure 5(h)).
The expression of the late neuronal marker NF, the
glial markers GFAP and S100, and the mesengenic markers
PPAR𝛾2, OPN, and OCN was not observed at any culture
passage examined.
Moreover, undifferentiated hPDLSCs that were positive
for NeuN also expressed 𝛽III-tubulin, while some 𝛽III-
tubulin positive cells were NeuN negative, as demonstrated
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(a) (b) (c)
(d) (e) (f)
(g) (h) (i)
Figure 7: Spontaneous expression of neural markers by undifferentiated hDPSCs (P4), after 14 days of culture. Actin filaments were labelled
in red ((a), (d), and (g)), and neural markers were labelled in green. About one-third of the cells in culture were nestin positive (b). Most
of cells were 𝛽III-tubulin positive (e) and numerous cells were NeuN positive with nuclear localization (h). Merges ((c), (f), and (i)). Bars:
50 𝜇m.
by double immunolabeling experiments (Figures 6(a)–6(c)).
In hPDLSC cultures, nestin positive cells were always 𝛽III-
tubulin positive (Figures 6(d)–6(f)) and, in some cases, they
were also NeuN positive (Figures 6(g)–6(i)).
3.1.4. Undifferentiated hDPSCs. For each marker, the per-
centage of hDPSC positive cells was obtained by averaging
experimental results using cells from 3 healthy donors.
The data reported in Table 4 refer to an average value
(mean ± SD) for a positive marker after 14 days of culture at
P2, P4, and P8.
At all the examined passages about 30% of undifferenti-
ated hDPSCs expressed the neuroprogenitor marker nestin
(Figure 7(b)), while more than 90% of cells were 𝛽III-tubulin
positive (Figure 7(e)) and about 50–60% were NeuN positive
(Figure 7(h)).
The expression of the late neuronal marker NF and the
glial markers GFAP and S100 was not observed at any culture
passage examined. Undifferentiated hDPSCs did not express
PPAR𝛾2, OPN, and OCN at any passage examined.
Moreover, double immunolabeling studies revealed that
undifferentiated hDPSCs that were positive for NeuN also
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(a) (b) (c)
(d) (e) (f)
(g) (h) (i)
Figure 8: Spontaneous coexpression of neural markers by undifferentiated hDPSCs (P8) after 14 days of culture. Most of cells were 𝛽III-
tubulin positive ((a), (d): red) and the numerous NeuN-positive cells ((b): green) were always 𝛽III-tubulin positive as shown in merge (c).
The nestin-positive cells ((e), (h): green) were always 𝛽III-tubulin positive as shown in merge (f), while only in some cases they were positive
for NeuN ((g): red) as shown in merge (i). Bars: 50𝜇m.
expressed 𝛽III-tubulin, while some 𝛽III-tubulin positive cells
were NeuN negative (Figures 8(a)–8(c)). In hDPSC cultures,
nestin positive cells were always 𝛽III-tubulin positive (Fig-
ures 8(d)–8(f)) and, in some cases, they were also NeuN
positive (Figures 8(g)–8(i)).
3.1.5. Statistical Comparison among Different MSC Types.
Among the neural markers evaluated, only 𝛽III-tubulin and
NeuN were expressed by all the various undifferentiated
mesenchymal-like stem cells from different sources. The
overall means of the percentage of cells expressing 𝛽III-
tubulin and NeuN for hASCs, hS-MSCs, hPDLSCs, and
hDPSCs were calculated and a statistical comparison of these
neuronal markers between the different MSC types studied
showed no significant differences (Table 5).
3.2. Evaluation of 𝛽III-Tubulin and NeuN Expressions by
Immunoblotting and FlowCytometry. 𝛽III-tubulin andNeuN
expressions in undifferentiated hASCs, hS-MSCs, hPDLSCs,
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Figure 9: Stem cells expression of𝛽III-tubulin andNeuN by immunoblotting. (a) Total protein extracts fromhASC (1), hS-MSC (2), hPDLSC
(3), hDPSC (4) and dorsal root ganglia (DRG) (5) cultures were separated by 13% SDS-PAGE and blotted with anti-𝛽III-tubulin antibody. A
50 kDa molecular weight band was evident in the protein extracts from all the stem cells of different sources examined, as in positive control
(DRG). Actin was used as loading control. (b). Nuclear protein extracts from hASC (1), hS-MSC (2), hPDLSC (3), hDPSC (4), and DRG (5)
cultures were separated by 13% SDS-PAGE and blotted with anti-NeuN antibody. All the different types of stem cells examined express the
two major NeuN species at 45–50 kDa, a reactive band at ∼66 kDa, and another one between 70–90 kDa, with an expression profile similar
to control. Actin was used as loading control.
and hDPSCs were evaluated through immunoblotting anal-
ysis. A band corresponding to a predicted 50 kDa molecular
weight was evident in all the donor’s total extracts examined
(Figure 9(a)). As regardsNeuN, the immunoblotting (nuclear
extracts), showed two major bands at 45–50 kDa and addi-
tional reactive bands at ∼66 kDa and between 70–90 kDa in
accordance with the literature data [25] (Figure 9(b)). For
all the stem cells of different origins examined, both 𝛽III-
tubulin and NeuN positivity was confirmed by means of flow
cytometric analysis, as shown in Figure 10.
4. Discussion and Conclusions
In this study, we have demonstrated that the early neuronal
marker 𝛽III-tubulin and the late neuronal marker NeuN,
unlike other evaluated markers, are expressed by a very high
percentage of undifferentiated hASCs, hS-MSCs, hPDLSCs,
and hDPSCs. These different types of stem cells sponta-
neously express the neuronal markers, in the absence of
any differentiative agent, at all the passages examined. Other
researchers have reported the expression of neural markers
by hASCs and by stem cells fromdental tissue [26–29], but no
extensive studies with a panel ofmarkers and culture passages
such as ours have been published before.
Until now the expressions of 𝛽III-tubulin and NeuN have
been considered to be limited to neuronal cells and have been
used to prove in vitro neuronal differentiation. Our findings
call into question these statements and raise the problem of
identifying a role for these proteins in stem cells.
𝛽III-tubulin is a constituent of neuronal microtubules
and is required in axon growth/guidance and in normal
brain development [16, 30]. However, the expression of 𝛽III-
tubulin has been observed in cells other than neuronal
ones such as tumor cells [31], perivascular cells (including
pericytes and smooth muscle cells) [32], normal large intes-
tine, fibroblasts, and keratinocytes [33]. Recently, alternative
functions for 𝛽III-tubulin have been proposed. Shibazaki
et al. [33] have demonstrated 𝛽III-tubulin involvement in
the cell division of non-neuronal cells and Bouchet et al.
[34] have shown that 𝛽III-tubulin is required for inter-
phase microtubule dynamics in human mammary epithelial
cells. Therefore, 𝛽III-tubulin could have different functions
depending on the cell type. The transcriptional regulation
of 𝛽III-tubulin represents another interesting aspect to be
evaluated. REST/NRSF is a transcriptional regulator that
binds to a highly conservedDNA sequence called RE1 located
in many neuronal genes and that silences their transcription
by recruiting specific corepressormulticomplexes [35]. In this
way REST/NRSF represses the expression of mature neuron
specific genes in non-neuronal cells and neuronal progenitors
preventing neuronal differentiation [36]. Shibazaki et al. [33]
have demonstrated that 𝛽III-tubulin expression is mediated
by REST/NRSF and that the 𝛽III-tubulin level increases only
in the G2/M phase when the occupancy in the RE-1 sequence
is minimal. Conversely, in tumor cells, in which 𝛽III-tubulin
is overexpressed, a dysregulation of REST/NRSF has been
proposed [33].
In our work a very high percentage of hASCs, hS-MSCs,
hPDLSCs, and hDPSCs are 𝛽III-tubulin positive suggesting
that 𝛽III-tubulin expression could, therefore, be an intrinsic
characteristic of these cells, probably being involved in their
cell growth. A dysregulation of REST/NRSF or of their
corepressors could explain why the level of 𝛽III-tubulin
expression is so high. Further studies will be necessary to
confirm this hypothesis.
NeuN is a neuron-specific nuclear protein and its expres-
sion is found only in postmitotic neurons [37]. Recently,
NeuN has been identified as Rbfox3, a member of the
RNA binding protein Fox-1 gene family [38]. NeuN/Rbfox3
regulates alternative splicing of Numb, a multifunctional
protein expressed by a wide variety of cells and involved
in many cellular processes including the maintenance of
stem cell compartments [39]. The regulation of Numb
by NeuN/Rbfox3 might not be restricted to neurons but
extended also to stem cells.This hypothesis could explainwhy
NeuN is expressed in all the MSC-like cells from the various
sources examined in this study. Moreover, the importance of
Numb has recently been demonstrated also in hDPSCs [40].
In our study, the percentage of cells expressing 𝛽III-
tubulin and NeuN was quite similar in the various MSC-
like cell types, although differences were evident regarding
the nestin expression. While nestin was expressed by a high
percentage of undifferentiated hPDLSCs and hDPSCs, only a
small number of undifferentiated hASCs and hS-MSCs were
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Figure 10: The undifferentiated stem cell expression of 𝛽III-tubulin and NeuN evaluated by flow cytometry analysis. 𝛽III-tubulin staining
histograms (pink) of undifferentiated hASCs (a), hS-MSCs (c), hPDLSCs (e), and hDPSCs (g) and the respective negative controls represented
by undifferentiated cells incubated with the appropriate APC-conjugated secondary antibody (white). NeuN staining histograms (pink) of
undifferentiated hASCs (b), hS-MSCs (d), hPDLSCs (f), and hDPSCs (h) and the respective negative controls represented by undifferentiated
cells incubated with the appropriate FITC-conjugated secondary antibody (white).
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nestin positive. The discrepancy observed in terms of the
percentage of nestin expressing cells could be explained by
taking into account the different origins of the stem cells
examined in our study. hPDLSCs and hDPSCs originate
from the neural crest [41] while for hASCs and hS-MSCs a
mesoderm origin has been proposed [42]. Since nestin is a
marker that is expressed not only by neural progenitors but
also by neural crest cells [43], it is reasonable to assume that
the high percentage of nestin positive hPDLSCs and hDPSCs
reflects their embryonic origin.
An interesting aspect of our study is that none of the
markers for mesodermal differentiation was spontaneously
expressed by the various types of stem cells we looked at.
This finding supports the hypothesis that the expression of
the neuronal markers, observed at very high levels, is not
aspecific but is probably related to the role played by these
proteins in undifferentiated stem cells.
In a previous study, we showed 𝛽III-tubulin and NeuN
expressions in undifferentiated human BM-MSCs [3] and the
percentages of cells expressing these markers were similar to
those observed for the MSC-like cells evaluated in this paper.
Our previous and current findings suggest that the expres-
sions of 𝛽III-tubulin and NeuN could be a common feature
of stem cells, regardless of the tissue from which the cells
are isolated. Moreover, the percentage of hBM-MSCs that
were nestin positive was similar to the percentage reported
for hASCs and hS-MSCS. Considering that BM-MSCs, like
hASCs and hS-MSCs, originate from the mesoderm, in
our opinion, this finding confirms that nestin expression
by undifferentiated stem cells is closely related to their
origin.
In conclusion, in this study we have demonstrated that,
like hBM-MSCs, undifferentiated stem cells from various
sources such as hASCs, hS-MSCs, hDPSCs, and hPDLSCs
spontaneously express the neuronal markers 𝛽III-tubulin
and NeuN. Further studies will be needed to analyze the
gene expression of these markers to verify if a different
regulation of these genes before and after differentiation
could occur. A deeper knowledge of the biological prop-
erties of stem cells derived from different tissues would
be very useful in view of their potential clinical applica-
tion in cell therapy as an alternative to MSCs from bone
marrow.
Last but not least, our results confirm that the evaluation
of marker expression can never be used as the only evidence
to prove the neuronal differentiation of MSC-like cells;
morphological changes and functional properties should also
be evaluated.
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